These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 29878908)

  • 1. Neuroimaging advances in Parkinson's disease.
    Rispoli V; Schreglmann SR; Bhatia KP
    Curr Opin Neurol; 2018 Aug; 31(4):415-424. PubMed ID: 29878908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging in Parkinson's Disease.
    Politis M; Pagano G; Niccolini F
    Int Rev Neurobiol; 2017; 132():233-274. PubMed ID: 28554409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging the Nonmotor Symptoms in Parkinson's Disease.
    Yousaf T; Wilson H; Politis M
    Int Rev Neurobiol; 2017; 133():179-257. PubMed ID: 28802921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo imaging of neuromelanin in Parkinson's disease using 18F-AV-1451 PET.
    Hansen AK; Knudsen K; Lillethorup TP; Landau AM; Parbo P; Fedorova T; Audrain H; Bender D; Østergaard K; Brooks DJ; Borghammer P
    Brain; 2016 Jul; 139(Pt 7):2039-49. PubMed ID: 27190023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging neurodegeneration in Parkinson's disease.
    Pavese N; Brooks DJ
    Biochim Biophys Acta; 2009 Jul; 1792(7):722-9. PubMed ID: 18992326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. JuSpace: A tool for spatial correlation analyses of magnetic resonance imaging data with nuclear imaging derived neurotransmitter maps.
    Dukart J; Holiga S; Rullmann M; Lanzenberger R; Hawkins PCT; Mehta MA; Hesse S; Barthel H; Sabri O; Jech R; Eickhoff SB
    Hum Brain Mapp; 2021 Feb; 42(3):555-566. PubMed ID: 33079453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroimaging approaches to cognition in Parkinson's disease.
    Montaser-Kouhsari L; Young CB; Poston KL
    Prog Brain Res; 2022; 269(1):257-286. PubMed ID: 35248197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroimaging and transcranial ultrasonography in Parkinson's disease.
    Mehta SH; Morgan JC; Sethi KD
    Curr Neurol Neurosci Rep; 2008 Jul; 8(4):297-303. PubMed ID: 18590613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of neuroimaging in Parkinson's disease.
    Bidesi NSR; Vang Andersen I; Windhorst AD; Shalgunov V; Herth MM
    J Neurochem; 2021 Nov; 159(4):660-689. PubMed ID: 34532856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of biomarkers and imaging in Parkinson's disease.
    Algarni MA; Stoessl AJ
    Expert Rev Neurother; 2016; 16(2):187-203. PubMed ID: 26829357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal Progression Markers of Parkinson's Disease: Current View on Structural Imaging.
    Yang J; Burciu RG; Vaillancourt DE
    Curr Neurol Neurosci Rep; 2018 Oct; 18(12):83. PubMed ID: 30280267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiotracers for imaging of Parkinson's disease.
    Abbasi Gharibkandi N; Hosseinimehr SJ
    Eur J Med Chem; 2019 Mar; 166():75-89. PubMed ID: 30685535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of structural and functional imaging in parkinsonian states with a description of PET technology.
    Brooks DJ
    Semin Neurol; 2008 Sep; 28(4):435-45. PubMed ID: 18843572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroimaging in Parkinson's disease: from pathology to diagnosis.
    Stoessl AJ
    Parkinsonism Relat Disord; 2012 Jan; 18 Suppl 1():S55-9. PubMed ID: 22166455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging Neuroimaging Biomarkers Across Disease Stage in Parkinson Disease: A Review.
    Mitchell T; Lehéricy S; Chiu SY; Strafella AP; Stoessl AJ; Vaillancourt DE
    JAMA Neurol; 2021 Oct; 78(10):1262-1272. PubMed ID: 34459865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroimaging in Parkinson's disease.
    Au WL; Adams JR; Troiano A; Stoessl AJ
    J Neural Transm Suppl; 2006; (70):241-8. PubMed ID: 17017536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parkinson's disease: imaging update.
    de la Fuente-Fernández R; Stoessl AJ
    Curr Opin Neurol; 2002 Aug; 15(4):477-82. PubMed ID: 12151846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroimaging in Parkinson's disease: focus on substantia nigra and nigro-striatal projection.
    Frosini D; Cosottini M; Volterrani D; Ceravolo R
    Curr Opin Neurol; 2017 Aug; 30(4):416-426. PubMed ID: 28537985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimizing diagnosis in Parkinson's disease: Radionuclide imaging.
    Arena JE; Stoessl AJ
    Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1():S47-51. PubMed ID: 26439947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging the Functional Neuroanatomy of Parkinson's Disease: Clinical Applications and Future Directions.
    Lauretani F; Longobucco Y; Ravazzoni G; Gallini E; Salvi M; Maggio M
    Int J Environ Res Public Health; 2021 Feb; 18(5):. PubMed ID: 33670940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.